Introduction Headspace GC-MS for Volatile Nitrosamine Analysis is a sophisticated and highly selective analytical technique widely employed to identify and […]
Introduction Nitrosamine Testing for Veterinary Drug Products is a critical analytical quality control process used to identify and quantify mutagenic
Introduction Nitrosamine Control Strategy Development Services offer a comprehensive, science-driven framework for identifying, quantifying, and controlling mutagenic N-nitroso impurities throughout
Introduction Nitrosamine Testing for Injectable Drug Products is a highly specialized analytical quality control procedure used to identify and quantify
Introduction: Implementation of Nitrosamine Testing for Injectable Drug Products is a critical safety and regulatory requirement because parenteral drug products
Introduction: The Expanding Regulatory Landscape for Nitrosamine Impurities in Biologics The nitrosamine crisis that affected the small-molecule pharmaceutical industry between
Introduction: Why Nitrosamines in Transdermal Patches and Topical Formulations Require Specialized Attention Over the past several years, the pharmaceutical and
Introduction: Nitrosamine Testing Inhalation Drug Products MDI DPI Nasal Spray has become a critical focus area for pharmaceutical manufacturers after
Nitrosamine Testing for Inhalation Drug Products: MDIs, DPIs, and Nasal Sprays Read More »
Introduction Pharmaceutical companies often receive regulatory questions about nitrosamine impurities during submissions, variations, or post-approval reviews. When this happens, organizations
How to Respond to a Regulatory Query on Nitrosamine Risk Assessment Read More »
Introduction: The Nitrosamine Batch Release Testing Requirement becomes mandatory when confirmatory testing shows nitrosamine impurity levels above 10% of the
Nitrosamine Batch Release Testing: When Is Routine Testing Required? Read More »
